Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study.
FILE PHOTO: An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues. Ulrich Perrey/Pool via REUTERS/File Photo
Remdesivir is being closely watched after the U.S. Food and Drug Administration granted emergency use authorization last month, citing results from another study run by the National Institutes of Health that showed the drug reduced hospitalization stays by 31%, or about four days, compared to a placebo.
The new results announced by Gilead on Monday are from a study designed to evaluate the safety and efficacy of 5- and 10-day treatment with remdesivir in addition to standard of care for patients with moderate COVID-19, compared with standard care alone.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Weiterlesen »
'I Just Couldn't Let Her Die Alone': Nurse FaceTimes COVID-19 Patient Through Final HoursCommentary: Linda Lombardi knew that her former patient had no family or close friends. So she used FaceTime to stay with her during her final hours in a special palliative care ward for COVID-19 patients. 'I just couldn't let her die alone,' she says.
Weiterlesen »
COVID-19 Takes Heavy Toll On People With Dementia — Even Those Who SurviveMany people with dementia who fall ill can’t express their symptoms, and early coronavirus markers may look similar to their other pre-existing conditions. That means COVID-19 can go undiagnosed in the early stages. hereandnow
Weiterlesen »
The world's new Covid-19 epicenter could be the worst yetAs new deaths and cases fall in the United States, Europe and Asia, Latin America now stands as the world's sole region where the outbreak is unequivocally reaching new heights.
Weiterlesen »